IPOPI

Improving PID patients’ lives. Worldwide. 

  • Home
  • About IPOPI
    • Mission and objectives
    • Executive Committee
    • Medical Advisory Panel
    • Staff
    • Member organisations
    • Network of Experts
    • History
    • IPOPI Governance
    • Corporate partners
    • Finances and transparency
  • Our Work
    • IPOPI strategic plan
      • Early diagnosis and care
      • NMO support
      • PID awareness
      • Stakeholder collaboration
    • Donate to IPOPI
  • PIDs
    • What are PIDs?
    • PIDs FAQs
    • COVID-19 and PIDs FAQs
  • NMOs
    • NMO Toolbox
    • NMO Documents
  • •
  • Menu
  • Publications
    • Leaflets
    • Reviews
    • Key publications
    • News
  • PID Life Index
  • Media
  • e-News
  • IPOPI TV
  • PID Genius
  • Leaflets
  • Physicians
10th August 2020

Haematopoietic stem cell transplatation

19th June 2020

APDS – Activated PI3K Delta syndrome

17th December 2019

A guide for pulmonologists

17th December 2019

A guide for gastroenterologists

17th December 2019

Value of SCID newborn screening

21st September 2019

A guide for general practitioners

19th June 2019

A guide for internal medicine specialists

19th June 2019

CVID management

10th January 2019

Primary immunodeficiencies and infections

10th January 2019

Primary immunodeficiencies and allergies

21st September 2017

How are primary immunodeficiencies classified?

21st September 2017

Immunoglobulin replacement therapy: one size doesn’t fit all

16th January 2015

Management after diagnosis

16th January 2015

PIDs and gastrointestinal disorders

16th January 2015

When to give immunoglobulin replacement therapy

6th January 2015

PIDs and respiratory disorders

20th December 2013

Plasma-derived therapies

20th December 2013

Autoimmunity and autoinflammation

20th December 2013

Vaccines and primary immunodeficiencies

2nd December 2012

Moving from child to adult care

2nd December 2012

Diagnosis of PID

20th March 2011

X-Linked Agammaglobulinemia

20th March 2011

Wiskott-Aldrich Syndrome

20th March 2011

Severe Combined Immunodeficiency

20th March 2011

Hyper IgM Syndrome

20th March 2011

Chronic Granulomatous Disease

  • Home
  • About IPOPI
    • Mission and objectives
    • Executive Committee
    • Medical Advisory Panel
    • Staff
    • Member organisations
    • Network of Experts
    • History
    • IPOPI Governance
    • Corporate partners
    • Finances and transparency
  • Our Work
    • IPOPI strategic plan
      • Early diagnosis and care
      • NMO support
      • PID awareness
      • Stakeholder collaboration
    • Donate to IPOPI
  • PIDs
    • What are PIDs?
    • PIDs FAQs
    • COVID-19 and PIDs FAQs
  • NMOs
    • NMO Toolbox
    • NMO Documents
  • Publications
    • Leaflets
    • Reviews
    • Key publications
    • News
  • PID Life Index
  • Media
  • e-News
  • IPOPI TV
  • PID Genius

Head Office

Rocky Bottom, Trerieve, Downderry,
PL11 3LY, United Kingdom
Tel/Fax: +44 1503 250 668/961
Email: info@ipopi.org

IPOPI is a non-profit charity registered in the UK under Charity number 1058005

Executive Office

Av. Aida, Bloco 8, escritório 821
2765-187 Estoril, Portugal
Tel: +351 21 407 5720
Email: info@ipopi.org

Social Media

Contact us

Calendar

Donate

Website sponsor

Copyright © 2020 IPOPI. All Rights Reserved.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read More
Privacy Policy
Necessary Always Enabled

Scroll to top